Bouyella Reddy, MD
Interventional Cardiology · Moline, ILNPI 1043299746
Payments from drug & device makers
What this record shows
This record is dominated by other: $169,667 of the $171,868 with a category attached, or 98.7%. Angiodynamics, Inc. accounts for 98.7% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $60,577 and has fallen 64.1% since, to $21,759 in 2025. Among interventional cardiology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 59 payments — averaging $2913.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$170K
- Philips North America LLC$779
- Medtronic$359
- Edwards Lifesciences$344
- Abbott$119
- Shockwave Medical, Inc$116
- plus $470 from 13 others
What the payments were for
- Travel & lodging$8611%
- Food & beverage$1,2401%
- Education$1000%
- Other$169,66799%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 8 | $169,680 |
| Philips North America LLC | 4 | $779 |
| Medtronic | 4 | $359 |
| Edwards Lifesciences | 11 | $344 |
| Abbott | 8 | $119 |
| Shockwave Medical, Inc | 4 | $116 |
| Astellas Pharma US Inc | 1 | $100 |
| Inari Medical, Inc. | 3 | $70 |
| Boston Scientific | 2 | $43 |
| Bard Peripheral Vascular, Inc. | 2 | $42 |
| Biosense Webster, Inc. | 1 | $37 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $35 |
| Abiomed | 2 | $31 |
| AstraZeneca | 2 | $29 |
| Cvrx, Inc. | 1 | $18 |
| Pfizer | 1 | $18 |
| Novartis | 1 | $16 |
| Merck | 1 | $15 |
| Cardinal Health 200 LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$169,667
- IGT D Peripheral$645
- Abre$316
How this compares
$171,868 in reported general payments places this provider in the 95th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 413 | $504,147 |
| EntrestoSacubitril/Valsartan | 317 | $460,588 |
| JardianceEmpagliflozin | 115 | $151,190 |
| XareltoRivaroxaban | 100 | $117,792 |
| Repatha SureclickEvolocumab | 72 | $67,158 |
| FarxigaDapagliflozin Propanediol | 62 | $64,824 |
| Praluent PenAlirocumab | 53 | $36,192 |
| BrilintaTicagrelor | 24 | $24,335 |
| Metoprolol Succinate | 1,022 | $18,322 |
| ClopidogrelClopidogrel Bisulfate | 1,255 | $14,496 |
| Atorvastatin Calcium | 914 | $8,694 |
| Carvedilol | 747 | $8,353 |
| Prasugrel Hcl | 81 | $7,077 |
| Valsartan | 138 | $5,842 |
| Ezetimibe | 237 | $5,221 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $18 | $504,147413 claims |
| NovartisEntresto | $16 | $460,588317 claims |
| AstraZenecaFarxiga, Brilinta | $29 | $89,15986 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 303 interventional cardiology providers in Illinois.
Other interventional cardiology in Moline
- Andrei PopElk Grove Village$900K
- Atman ShahChicago$788K
- Ravi RamanaPalos Park$458K
- Mahesh RajuDowners Grove$281K
- Mark RicciardiEvanston$253K
- Neal SawlaniPark Ridge$246K
- Tony de MartiniSpringfield$208K
- David StewartChicago$169K
- Jaafer GolzarOak Lawn$152K
- Sudhir MungeePeoria$146K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.